Comparison of flagellin and an oil-emulsion adjuvant in inactivated Newcastle disease vaccine in stimulation of immunogenic parameters

The present study was designed to investigate the potential application of native (N) and recombinant (truncated modified [tmFliC] and full-length [flFliC]) flagellin proteins along with inactivated Newcastle disease virus (NDV). Fifty six SPF chickens were immunized twice with PBS (control), inactivated NDV (Ag), inactivated NDV/flFliC (AgF), inactivated NDV/tmFliC (AgT), inactivated NDV/N (AgN), commercial vaccine containing Montanide (Vac) and Vac/N (VacN), with a two-week interval. Blood was collected weekly and spleens were harvested after chickens were sacrificed. Interleukin-6 (IL-6) and tumor necrotic factor-α (TNF-α) gene expression in peripheral blood mononuclear cells were analyzed by Real-Time PCR. Antibody response was assessed by haemagglutination inhibition (HI). Cellular activity was quantified by MTT assay. Results showed that the most IL-6 and TNF-α gene expression was observed in AgF group (P < 0.01). The lowest gene expression among vaccinated groups was observed in Ag group for IL-6 and Ag and Vac group for TNF-α. The highest HI titer was observed in Vac, VacN, AgF and AgT groups. The AgF group showed the highest cellular activity (P < 0.01). In conclusion, flagellin-adjuvanted groups showed a pro-inflammatory effect and acted similarly to or better than the Vac group. Hence, flagellin can be proposed as a potential adjuvant for ND vaccine.     

鸡新城疫病毒F基因和鸡IL—2重组DNA疫苗的构建

利用已克隆到的新城疫D26株F基因和鸡IL－2基因，经过载体改建，将他们共同克隆于真核表达质粒pCDNA3上，经酶切分析、PCR鉴定证实成功构建了共表达鸡新城疫病毒F基因和鸡IL－2的重组质粒，为探讨禽类重组基因疫苗的构建及鸡IL－2在基因疫苗中的作用奠定了基础。     

我国部分地区ＮＤＶ的分子流行病学研究

本研究根据新城疫病毒（ＮＤＶ）Ｆ基因编码区１－３７４位核苷酸序列计算其遗传距离并给出了ＮＤＶ的系统发育进化树，将６８株ＮＤＶ分为９个基因型（３０株为国内分离株），其中Ⅰ－Ⅵ是早已存在的老基因型，Ⅶ、Ⅷ、Ⅸ为新发现的基因型，特别是Ⅸ为我国特有的基因型（Ｆ４８ＥＯ、Ｍ３、ＨＬＪ－３、ＨeB-1P和ＮＭ－５）。１９９７－１９９９年我国云南、广西、甘肃、陕西、新疆等地分离的ＹＮ－１Ｐ、ＧＸ－３、Ｈ１、Ｈ２、Ｐ１、ＧＸ－１、ＧＸ－２、ＧＳ－３、ＳＨＸ－２、ＳＨＸ－３、ＳＨＸ－６、ＳＨＸ－７、ＸＪ－２和１９９１年分离的ＨuB-1均属于Ⅶ基因型，该基因型的病毒是９０年以来引起新城疫发生的主要病原。根据遗传距离和分离年代可将此基因型进一步划分为５个基因亚型，分别是Ⅶa、Ⅶb、Ⅶc、Ⅶd和Ⅶe。此外ＨuN-1/98、HLJ-4/95和ＨeH-1P属一个老的基因Ⅵ，１９７９－１９８５年分离自青海的ＱＨ－１、ＱＨ－２、ＱＨ－４属于一个新的基因型－Ⅷ型。可见在我国新城疫的流行是极其复杂的，既有老基因型的危害（Ⅰ－Ⅵ），又有新基因型（Ⅶ）的流行，更有我国独特Ⅷ和Ⅸ基因潜伏。     

新城疫（ND）—减蛋综合征（EDS76）蜂胶二联灭活疫苗的研制Ⅰ．制苗工艺、疫苗安全性和免疫原性试验

将新城疫病毒（NDV）Colon-30株和减蛋综合征病毒（EDS76AV）－127株分别接种于非免疫鸡胚和鸭胚，制备抗原液。抗原液经甲醛灭活后，与纯化的天然免疫增强剂蜂胶乳化，制成鸡新城疫（ND）－减蛋综合征（EDS76）蜂胶二联灭活疫苗，对疫苗的安全性和免疫原性进行了测定。对3－6周龄易感雏鸡以2倍使用剂量肌内注射，安全性良好；对1日龄雏鸡接种1个使用剂量进行急性毒性试验。15d生长曲线表明，对雏难 影响。对6周龄雏鸡注射1个使用剂量，每批疫苗免疫10只鸡，免疫后5－32d，鸡血清中EDS76血凝抑制（HI）抗体的几何平均滴度（GMT）为6．5－11．8log2,ND血凝抑制（HI）抗体的几何平均滴度（GMT）为4．8－9．8log2；对ND免疫攻毒试验表明，3批疫苗，每羽份含有的半数保护量（PD50）分别为≥127、≥131和≥127。     

应用生物素标记的NDV－cDNA探针检测感染尿囊液中NDV－RNA的初步研究

本文应用聚合酶链反应（ＰＣＲ）技术从构建的新城疫病毒（ＮＤＶ）ｃＤＮＡ文库中扩增含编码Ｆ糖蛋白前体──Ｆｏ酶切位点序列的３５９ｂｐ的Ｆ蛋白基因ｃＤＮＡ片段。将此３５９ｂｐｃＤＮＡ片段经光敏生物素标记后,即成ＮＤＶ－ｃＤＮＡ探针。该探针能特异性地从感染的尿囊液中检测出ＮＤＶ强毒株和疫苗毒株的基因组ＲＮＡ,而不与ＩＢＤｖ－ｄｓＲＮＡ、ＡＩＢｖ－ｓｓＲＮＡ、ＥＤＳ７６－ｄｓＤＮＡ、ＭＤＶ－ｄｓＤＮＡ,ＦＰＶ－ｄｓＲＮＡ及ＡＩＬＶ－ｄｓＤＮＡ发生交叉杂交反应。试验结果表明：尽管该探钎含有编码Ｆｏ蛋白酶切位点序列的碱基顺序,但它还是不能把ＮＤＶ的强、弱毒株区分开。这说明ＮＤＶ强、弱毒株比区域内的碱基存在着相当大的同源性。不过,此探针对ＮＤＶ来说具有特异性,这就为ＮＤＶ的诊断技术开创了基因水平检测的新途径。     

Kinetics of NDV specific antibodies in chickens—V. Analysis of frequency distributions of antibody titers against Newcastle disease virus by investigation of random samples in chicken flocks

Chicks and chickens maintained under commercial conditions were vaccinated against Newcastle Disease via drinking water. Prior and after different times of vaccination blood samples were drawn from different numbers of birds and checked for HI antibodies. The modes of distribution of the antibody titers within the random sample were assayed. The following results were obtained:

1. 1. On the basis of the distribution of the serum titers can be concluded whether the antibody level within a flock is increasing or decreasing.

◦ —A right steep asymmetry can be observed up to 20 days post vaccination.

◦ —In the phase of maximal antibody levels an almost symmetric distribution of the titers is present.

◦ —In later times (more than three weeks p. vacc.) the distribution shows a left steep asymmetry (Poisson distribution).

2. 2. A poisson distribution is also observable during the elimination of maternal antibodies of chicks until complete elimination.

3. 3. The mode of distribution of the HI titers in sera of day-old chicks correlates with the mode of distribution of the dams. Therefore, conclusions are possible from the status of the chicks to the dams and reverse.

4. 4. Factors which interfere with the mode of distribution are:

◦ —Two or more peaks after vaccination of chickens. This indicates an uneven immune response within the flock.

◦ —Distributions with several peaks may also occur if flocks are composed of day-old chicks from parent flocks with different levels of antibody titers.

中药穿心莲对新城疫HI抗体滴度的影响

1日龄肉仔鸡随机分为A、B、C、D、E、F、G7个试验组,每组组内设2个重复小组,每个重复小组35只鸡。A、B、C、D、E、F试验组添加穿心莲,G组不添加。各组均对新城疫进行首免和二免。结果发现,穿心莲能显著提高肉鸡的新城疫HI抗体滴度水平。另外,穿心莲的抗体滴度水平有一定的剂量依赖性,随着剂量的上升效果有提高的趋势。     

鸡痘病毒通用高效表达载体的构建及其初步应用

利用分子克隆技术对本室构建的高效鸡痘病毒表达载体 p1 1 S进行改造 ,在其人工合成禽痘病毒 ( FPV)强启动子 Ps的下游引入含 7个单一酶切位点的多克隆位点 ( MCS) ,构建了便于外源基因插入的通用性更强的高效单表达载体 p N1 1 S。然后将 FPV早晚期启动子 PE/ L 及其启动的鹅源新城疫病毒 NDV ZJ1株的 F基因一并插入 p N1 1 S中 ,使PE/ L 与 Ps反向串联 ,从而构建出 1个含 NDV ZJ1株 F基因的重组 FPV高效双表达载体 p N1 1 SEF,其 MCS可以用于插入其他外源基因。在此基础上 ,将 NDV ZJ1株的 HN基因插入 p N1 1 SEF的 Ps启动子下游的 MCS中 ,构建了共表达 NDV ZJ1株 F和 HN基因的重组 FPV双表达载体 p N1 1 SEFHN。将 p H1 1 SEFHN质粒 DNA与 FPV2 82 E4株共转染 CEF,得到共表达 NDV ZJ1株和 HN基因的重组 FPV,间接免疫荧光实验初步证明外源基因得到了较好的表达。表明所构建的通用高效 FPV表达载体有利于高效基因工程活载体疫苗的研制 ,具有广阔的应用前景     

鸡IL-18真核表达载体的构建及其对新城疫疫苗免疫增强作用的研究

利用首次从鸡新城疫疫苗接种的鸡胚脾细胞中扩增出的鸡IL 18 全基因,构建IL 18 真核表达载体(pcDNA3 IL18),并观察其对新城疫疫苗的免疫增强作用。结果表明,同时接种pcDNA3 IL18 质粒和活疫苗的免疫鸡在接种后35 d内,特别是15 d之后所产生的HI抗体效价和T、B淋巴细胞增殖反应均高于单纯疫苗免疫组及pcDNA3 空白质粒和疫苗联合免疫组。其中,HI抗体效价在15 d 时差异显著(P<0 05),在30 和35 d时差异极显著(P<0 01); T淋巴细胞增殖反应在15 d后均表现为差异显著(P<0 05〉或极显著(P<0 01);而单纯疫苗组与空白质粒和疫苗联合免疫组之间的各测定指标则无明显的差异(P>0 05)。在35 d时进行攻毒, pcDNA3 IL18和疫苗联合免疫组的保护率为83.3%,而单纯疫苗免疫组、空白质粒和疫苗联合免疫组鸡的保护率则分别只有61.5%和66.7%。说明该pcDNA3 IL18真核表达质粒在鸡体内得到了表达,表达产物不仅能够显著增强新城疫疫苗所诱导的细胞免疫和体液免疫反应,而且还可以明显提高疫苗的保护率。     

人工诱发鸡新城疫的攻毒条件的比较研究

将4周龄淮南麻黄鸡80羽随机平均分成4组：口鼻接种组、皮下接种组、肌肉接种组和空白对照组，分别用不同稀释度的NDV攻毒，观察攻毒结果并统计死亡情况。结果不同攻毒途径的致病性有差异，肌肉注射致病性最强，皮下注射次之，滴鼻滴口最弱。不同攻毒途径所需的攻毒剂量各不相同，滴鼻滴口所需的剂量最大，皮下注射次之，肌肉注射量最小。本文对造成不同攻毒途径致病性差异的原因进行了深入探讨。人工诱发新城疫，建议采用注射途径。